The combination paclitaxel, carboplatin and megestrol acetate is effectivein women with recurrent uterine papillary serous adenocarcinoma

Authors
Eltabbakh, GH Moody, J Garafano, LL Hammond, JM
Citation
Gh. Eltabbakh et al., The combination paclitaxel, carboplatin and megestrol acetate is effectivein women with recurrent uterine papillary serous adenocarcinoma, EUR J GYN O, 20(1), 1999, pp. 18-19
Citations number
13
Categorie Soggetti
Reproductive Medicine
Journal title
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
ISSN journal
03922936 → ACNP
Volume
20
Issue
1
Year of publication
1999
Pages
18 - 19
Database
ISI
SICI code
0392-2936(1999)20:1<18:TCPCAM>2.0.ZU;2-B
Abstract
Uterine papillary serous adenocarcinoma is an uncommon and very aggressive type of endometrial cancer. A 70-year-old patient diagnosed with recurrent uterine papillary serous adenocarcinoma was prescribed megesterol acetate ( 160 mg daily), paclitaxel (135 mg/m(2)) and carboplatin (area under the con centration-time curve of 5) every 4 weeks for 4 courses. She demonstrated c omplete clinical response that was maintained for longer than 6 months with minimal toxicity. The combination megesterol acetate, paclitaxel and carbo platin may be effective in women with recurrent uterine papillary serous ad enocarcinoma.